Skip to main content
OpenTrials

Clinical trial condition

Relapsing Multiple Sclerosis

Explore clinical trials studying Relapsing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

68 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Multiple Sclerosis trial results

Completed

Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017)

NCT01939002

Conditions
Relapsing Multiple Sclerosis
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
View all 38 locations
View Trial Details
Completed

Long-Term Safety and Efficacy Study of Peginterferon Beta-1a

NCT01332019

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • Research Site Atlanta, Georgia, United States
  • Research Site Lexington, Kentucky, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Raleigh, North Carolina, United States
View all 151 locations
View Trial Details
Completed

Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

NCT00906399

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Ponte Vedra Beach, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Des Moines, Iowa, United States
View all 178 locations
View Trial Details

Related conditions